Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan

American Journal of Gastroenterology

Volumn 94, Issue 10, 1999, Pages 2834-2839

  Wang, Liang Shun ^a   Chow, Kuan Chih ^b   Wu, Yu Chung ^a   Li, Wing Yin ^a   Huang, Min Hsiung ^a  

^a Section of Chest Surgery   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; FAS LIGAND; INTERLEUKIN 6; LATENT MEMBRANE PROTEIN 1; PEROXIDASE; PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TAIWAN; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS;

AGED; ANTIGENS, CD45; ANTIGENS, VIRAL; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; ESOPHAGEAL NEOPLASMS; FAS LIGAND PROTEIN; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERLEUKIN-6; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TAIWAN; TUMOR SUPPRESSOR PROTEIN P53; VIRAL MATRIX PROTEINS;

EID: 0032820117     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01425.x     Document Type: Article

References (44)

1. Wu Y.K., Chen P.T., Fang J., et al. Surgical treatment of esophageal carcinoma. Am J Surg. 139:1980;805-809.
2. Wang L.S., Huang M.H., Huang B.S., et al. Gastric substitution for resectable carcinoma of the esophagus. An analysis of 368 cases. Ann Thorac Surg. 53:1992;289-294.
3. Li J.Y. Epidemiology of esophageal cancer in China. NCI Monogr. 62:1982;113-120.
4. Cheng K.K. The etiology of esophageal cancer in Chinese. Semin Oncol. 21:1994;411-415.
5. Carter C.L., Hu N., Wu M., et al. Segregation analysis of esophageal cancer in 221 high-risk Chinese families. J NCI. 84:1992;771-776.
6. Mellow M.H., Layne E.A., Lipman T.O., et al. Plasma zinc and vitamin A in human squamous carcinoma of the esophagus. Cancer. 51:1983;1615-1620.
7. Rao M., Liu F.S., Dawsey S.M., et al. Effects of vitamin/mineral supplementation on the proliferation of esophageal squamous epithelium in Linxian, China. Cancer Epidemiol Biomarkers Prev. 3:1994;277-279.
8. Bartsch H., Ohshima H., Pignatelli B., et al. Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics. 2:1992;272-277.
9. Schroeder J.J., Crane H.M., Xia J., et al. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme. J Biol Chem. 269:1994;3475-3481.
10. Hecker E., Lutz D., Weber J., et al. Multistage tumor development in the human esophagus - The first identification of cocarcinogens of the tumor promoter type as principal carcinogenic risk factors in a local life style cancer. Prog Clin Biol Res. 132B:1983;219-238.
11. Chang F., Syrjanen S., Wang L., et al. Infectious agents in the etiology of esophageal cancer. Gastroenterology. 103:1992;1336-1348.
12. Chang F., Syrjanen S., Shen Q., et al. Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China. Int J Cancer. 45:1990;21-25.
13. Lam K.Y., He D., Ma L., et al. Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. Hum Pathol. 28:1997;657-663.
14. Rugge M., Bovo D., Busatto G., et al. p53 Alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy. Cancer Epidemiol Biomarkers Prev. 6:1997;171-176.
15. Akutsu N., Shirasawa H., Nakano K., et al. Rare association of human papillomavirus DNA with esophageal cancer in Japan. J Infect Dis. 171:1995;425-428.
16. Suzuk L., Noffsinger A.E., Hui Y.Z., et al. Detection of human papillomavirus in esophageal squamous cell carcinoma. Cancer. 78:1996;704-710.
17. Saegusa M., Hashimura M., Takano Y., et al. Absence of human papillomavirus genomic sequences detetcted by the polymerase chain reaction in esophageal and gastric carcinoma in Japan. Mol Pathol. 50:1997;101-104.
18. Mizobuchi S., Sakamoto H., Tachimori Y., et al. Absence of human papillomavirus-16 and -18 DNA and Epstein-Barr virus DNA in esophageal squamous cell carcinoma. Jpn J Clin Oncol. 27:1997;1-5.
19. Spring S.B., Schluederberg A., Allen W.P., et al. Pathogenic diversity of Epstein-Barr virus. J Natl Cancer Inst. 81:1989;13-20.
20. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA. 59:1968;94-99.
21. Eversole L.R., Stone C.E., Beckmann A.M. Detection of EBV and HPV DNA sequences in oral "hairy" leukoplakia by in situ hybridization. J Med Virol. 26:1988;271-276.
22. Desgranges C., Wolfe H., de-The G. Nasopharyngeal carcinoma, X Presence of Epstein-Barr virus genomes in separated epithelial cells of tumors in patients from Singapore, Tunisia, and Kenya . Int J Cancer. 16:1975;7-15.
23. Simon M. Jr, Hunyadi J., Dobozy A. Expression of complement receptor CR2 (CD21) on human keratinocytes in normal and diseased skin. Dermatologica. 183:1991;184-186.
24. Allday M.J., Crawford D.H. Role of epithelium in EBV persistence and pathogenesis of B-cell tumors. Lancet. 301:1988;855-857.
25. Slaughter D.P., Southwick H.W., Smejkal W. "Field canceriztion" in oral stratified squamous epithelium. Cancer. 6:1953;963-968.
26. Ho H.C., Ng M.H., Kwan H.C. Factors affecting serum IgA antibodies to Epstein-Barr viral capsid antigens in nasopharyngeal carcinoma. Br J Cancer. 37:1978;356-362.
27. Sporn M.B., Roberts A.B. Autocrine growth and cancer. Nature. 313:1985;745-747.
28. Walker P.R., Saas P., Dietrich P.Y. Role of Fas ligand (CD95L) in immune escape The tumor cell strikes back . J Immunol. 158:1997;4521-4524.
29. Liu C.C., Fahn H.J., Wu Y.C., et al. Lymph node metastasis in squamous cell carcinoma of the intrathoracic esophagus. Chin Med J (Taipei). 61:1998;77-84.
30. Chow K.C., Nacilla J.Q., Witzig T.E., et al. Is persistent polyclonal B lymphocytosis caused by Epstein-Barr virus? A study with polymerase chain reaction and in situ hybridization. Am J Hematol. 41:1992;270-275.
31. Arai E., Chow K.C., Li C.Y., et al. Differentiation between cutaneous form of adult T cell leukemia/lymphoma and cutaneous T cell lymphoma by in situ hybridization using a human T cell leukemia virus-1 DNA probe. Am J Pathol. 144:1994;1-6.
32. Wilczynski S.P., Lin B.T., Xie Y., et al. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological pattern of tonsillar squamous cell carcinoma. Am J Pathol. 152:1998;145-156.
33. Chen C.M., Shyu M.P., Au L.C., et al. Analysis of deletion of the integrated human papillomavirus 16 sequence in cervical cancer A rapid multiplex polymerase chain reaction approach . J Med Virol. 44:1994;206-211.
34. Glickman J.N., Howe J.G., Steitz J.A. Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J Virol. 62:1988;902-911.
35. Chang Y.T., Liu H.N., Chow K.C., et al. Detection of Epstein-Barr virus in primary cutaneous amyloidosis. Br J Derm. 136:1997;823-826.
36. Wong G.G., Witek-Giannotti J., Hewick R.M., et al. Interleukin 6 Identification as a hematopoietic colony-stimulating factor . Behring Inst Mitt. 83:1988;40-47.
37. Chiu C.F., Chow K.C., Lin F.M., et al. Expression of DNA topoisomerase IIα and multidrug resistance p-glycoprotein in acute leukemia. Chin Med J (Taipei). 60:1997;184-190.
38. Mori M., Watanabe M., Tanaka S., et al. Epstein-Barr virus-associated carcinomas of the esophagus and stomach. Arch Pathol Lab Med. 118:1994;998-1001.
39. Jenkins T.D., Nakagawa H., Rustgi A.K. The association of Epstein-Barr virus DNA with esophageal squamous cell carcinoma. Oncogene. 13:1996;1809-1813.
40. Chow K.C., Chiou S.H., Wu L.J., et al. Significance of soluble interleukin-2 receptor in patients with nasopharyngeal carcinoma. Werner J.A., Lippert B.M., Rubert H.H. Head and neck cancer Advances in basic research . 1996;545-549 Elsevier, Amsterdam.
41. Rowe M., Lear A.L., Croom-Carter D., et al. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol. 66:1992;122-131.
42. Dreno B., Celerier P., Fleischmann M., et al. Presence of Epstein-Barr virus in cutaneous lesions of mycosis fungoides and Sezary syndrome. Acta Derm Venereol (Stockh). 74:1994;355-357.
43. Strassmann G., Jacob C.O., Evans R., et al. Mechanism of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia. J Immunol. 148:1992;3674-3678.
44. Oka M., Yamamoto K., Takahashi M., et al. Relationship between serum levels of interleukin 6, various disease parameters, and malnutrition in patients with esophageal carcinoma. Cancer Res. 56:1996;2776-2780.